Theravance Biopharma Inc (TBPH)
Financing Cash Flow
$4.61M
Quarterly · Period ending: · USD
TBPH Financing Cash Flow
Latest reported$4.61Mperiod ending
Latest reported$4.61Mperiod ending
TBPH Quarterly Cash from Financing ($25.28M → $4.61M)
Quarterly financing cash flow
High-resolution chart · PNG
TBPH financing cash flow history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Financing Cash Flow (USD) |
|---|---|
| 4,610,000 | |
| -5,577,000 | |
| -1,491,000 | |
| -400,000 | |
| -503,000 | |
| -854,000 | |
| -365,000 | |
| -372,000 | |
| -44,000 | |
| -1,716,000 | |
| -30,609,000 | |
| -31,404,000 | |
| -80,680,000 | |
| -56,240,000 | |
| -35,472,000 | |
| -722,026,000 | |
| 140,000 | |
| -1,448,000 | |
| 149,000 | |
| -2,286,000 | |
| 105,285,000 | |
| -11,288,000 | |
| 743,000 | |
| -963,000 | |
| 1,873,000 | |
| 261,432,000 | |
| -1,544,000 | |
| -134,000 | |
| 4,402,000 | |
| -1,433,000 | |
| 229,604,000 | |
| -322,000 | |
| -2,402,000 | |
| -1,680,000 | |
| 631,000 | |
| -789,000 | |
| 3,030,000 | |
| -1,216,000 | |
| 332,455,000 | |
| 481,000 | |
| 120,270,000 | |
| 26,020,000 | |
| 53,842,000 | |
| -82,000 | |
| 1,506,000 | |
| 26,044,000 | |
| -158,000 | |
| 262,000 | |
| 324,098,000 | |
| 46,419,000 | |
| 36,254,000 | |
| 33,172,000 | |
| 25,036,000 | |
| 29,131,000 | |
| 22,968,000 | |
| 25,282,000 |